Wolint Petra, Hofmann Silvan, von Atzigen Julia, Böni Roland, Miescher Iris, Giovanoli Pietro, Calcagni Maurizio, Emmert Maximilian Y, Buschmann Johanna
Division of Surgical Research, University Hospital of Zurich, 8091 Zurich, Switzerland.
Department of Plastic Surgery and Hand Surgery, University Hospital Zurich, 8091 Zurich, Switzerland.
Int J Mol Sci. 2024 Dec 31;26(1):291. doi: 10.3390/ijms26010291.
Regeneration after ischemia requires to be promoted by (re)perfusion of the affected tissue, and, to date, there is no therapy that covers all needs. In treatment with mesenchymal stem cells (MSC), the secretome acts via paracrine mechanisms and has a positive influence on vascular regeneration via proangiogenic factors. A lack of standardization and the high complexity of vascular structures make it difficult to compare angiogenic readouts from different studies. This emphasizes the need for improved approaches and the introduction of an index in the preclinical setting. A characterization of human MSC secretomes obtained from one of the three formats-single cells, small, and large spheroids-was performed using the chicken aortic ring assay in combination with a modified angiogenic activity index (AAI) and an angiogenic profile. While the secretome of the small spheroid group showed an inhibitory effect on angiogenesis, the large spheroid group impressed with a fully pro-angiogenic response, and a higher AAI compared to the single cell group, underlying the suitability of these three-stem cell-derived secretomes with their distinct angiogenic properties to validate the AAI and the novel angiogenic profile established here.
缺血后的再生需要通过受影响组织的(再)灌注来促进,并且迄今为止,尚无涵盖所有需求的治疗方法。在用间充质干细胞(MSC)进行治疗时,分泌组通过旁分泌机制起作用,并通过促血管生成因子对血管再生产生积极影响。缺乏标准化以及血管结构的高度复杂性使得难以比较不同研究中的血管生成读数。这强调了在临床前环境中需要改进方法并引入一个指标。使用鸡主动脉环试验结合改良的血管生成活性指数(AAI)和血管生成图谱,对从三种形式之一——单细胞、小和大球体——获得的人MSC分泌组进行了表征。虽然小球体组的分泌组对血管生成显示出抑制作用,但大球体组表现出完全促血管生成反应,并且与单细胞组相比具有更高的AAI,这表明这三种干细胞来源的分泌组具有不同的血管生成特性,适合用于验证在此建立的AAI和新的血管生成图谱。